2025-01-24 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Review

**1. Performance Relative to S&P 500 (VOO):**

UnitedHealth Group Inc (UNH) is a diversified healthcare company offering a range of products and services.  Over the measured period, UNH significantly outperformed the S&P 500 (VOO). The cumulative return for UNH was 144.35%, while the S&P 500's cumulative return was 122.83%.  The difference is a 21.5% outperformance.  The relative outperformance, considering historical volatility, places UNH in the 81.6th percentile (100-(100* (21.5- (-4.2))/(135.7-(-4.2))) based on the provided data.

**Alpha and Beta Analysis:**

The provided data shows UNH consistently exhibiting positive alpha (outperformance relative to the market), ranging from 0.1 to 0.5 in the given periods.  Beta values also fluctuate, reflecting changing market sensitivities.   The recent negative CAGR is a significant point that should be investigated.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 65.0% | 12.4% | 38.0% | 0.1 | 488.0 |
| 2016-2018  | 64.0% | 18.6% | 50.0% | 0.1 | 488.0 |
| 2017-2019  | 52.0% | 20.2% | 21.0% | 0.1 | 488.0 |
| 2018-2020  | 44.0% | 35.3% | 10.0% | 0.1 | 488.0 |
| 2019-2021  | 114.0% | 35.3% | 34.0% | 0.1 | 488.0 |
| 2020-2022  | 89.0% | 35.3% | 82.0% | 0.1 | 488.0 |
| 2021-2023  | 51.0% | 16.2% | 27.0% | 0.1 | 488.0 |
| 2022-2024  | -40.0% | 21.9% | -62.0% | 0.1 | 488.0 |
| 2023-2025  | -20.0% | 21.9% | -94.0% | 0.1 | 488.0 |


**2. Recent Price Movement:**

* **Closing Price:** $529.77
* **5-day Moving Average:** $518.97
* **20-day Moving Average:** $518.05
* **60-day Moving Average:** $552.71

The price is currently above its 5-day and 20-day moving averages but below its 60-day moving average, suggesting a potential short-term upward trend but a longer-term downward trend.  The recent price increase of $10.05 (from $519.72 previous close) is notable, indicating a potential short-term price surge.


**3. Technical Indicators and Expected Return:**

* **RSI:** 60.60 (Slightly above neutral; not overbought)
* **PPO:** 0.55 (Positive, suggesting bullish momentum)
* **Relative Strength Change (20-day):** -8.9% (Short-term weakening)
* **Expected Return (Long-term):** 353.7% (Significantly higher than S&P 500 over the long term).  This figure is extremely high and requires deeper investigation into the methodology for its calculation.



**4. Recent Earnings Analysis:**

The earnings data shows some volatility.  There's a significant drop in EPS in Q2 2024 (-1.53), followed by a recovery. The most recent quarter (2024-11-04) shows strong revenue and EPS.  Further analysis is needed to understand the reasons behind the Q2 drop and the overall trend.


| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2024-11-04 | 6.56 | $100.82 B     |
| 2024-08-09 | 4.58 | $98.86 B     |
| 2024-05-09 | -1.53 | $99.80 B     |
| 2023-11-06 | 6.31 | $92.36 B     |
| 2024-11-04 | 6.31 | $92.36 B     | *(Duplicate entry, likely an error)*


**5. Financial Information:**

Revenue is relatively consistent, showing steady growth. Profit margins show some fluctuation but generally remain strong.  ROE (Return on Equity) fluctuates significantly, indicating potential operational or market-related factors affecting profitability.  The negative ROE in Q1 2024 warrants further investigation.


**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-09-30 | $99.18B     | 21.56%        |
| 2024-06-30 | $97.86B     | 21.52%        |
| 2024-03-31 | $98.78B     | 22.26%        |
| 2023-12-31 | $93.25B     | 22.33%        |
| 2023-09-30 | $91.36B     | 24.51%        |

**Capital and Profitability:**

| Quarter | Equity      | ROE   |
|---------|-------------|-------|
| 2024-09-30 | $94.53B     | 6.41% |
| 2024-06-30 | $89.36B     | 4.72% |
| 2024-03-31 | $86.69B     | -1.63%|
| 2023-12-31 | $88.76B     | 6.15% |
| 2023-09-30 | $84.49B     | 6.91% |


**7. Overall Analysis:**

UNH has historically outperformed the S&P 500, showing strong revenue and profit margins. However, recent data reveals some volatility in earnings and ROE, alongside a significant decline in CAGR. The high long-term expected return needs verification and justification.  The current price action shows some short-term strength but the stock price remains below the 60-day moving average.  Further investigation is needed into the causes of recent fluctuations and the sustainability of future outperformance.  A thorough review of the methodologies for calculating both the 353.7% expected return and the Alpha values from the provided historical data is crucial.


**8. Disclaimer:** This analysis is based on the limited data provided. It is not financial advice.  Conduct thorough due diligence and consult with a financial advisor before making any investment decisions.
